Healthcare -
Biotechnology - NASDAQ - US
$ 19.94
-0.697 %
$ 1.58 B
Market Cap
-4.62
P/E
VRDN - OTHER CURRENT LIABILITIES
Other Current Liabilities VRDN - Viridian Therapeutics, Inc.
23.3 M
LAST VALUE
48.87%
2 YEAR CAGR
43.17%
5 YEAR CAGR
46.43%
10 YEAR CAGR